ABT-072

DB15156InvestigationalSmall molecule

ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat...

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₂₄H₂₇N₃O₅S · 469.56 g/mol (avg)
Code names: ABT-072

Resolves to

Compound

UNIIPSQ4R5K1QICAS1132936-00-5ChEMBLCHEMBL4076467

Structure

InChIKeyXMZSTQYSBYEENY-RMKNXTFCSA-NSMILESCOC1=C(\C=C\C2=CC=C(NS(C)(=O)=O)C=C2)C=C(C=C1C(C)(C)C)N1C=CC(=O)NC1=O

Targets

O39930NS5bP26664Genome polyprotein

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with ABT-072, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account